IceCure Medical Future Growth
Future criteria checks 2/6
IceCure Medical is forecast to grow earnings and revenue by 54.8% and 47.8% per annum respectively while EPS is expected to grow by 55.6% per annum.
Key information
54.8%
Earnings growth rate
55.6%
EPS growth rate
| Medical Equipment earnings growth | 16.2% |
| Revenue growth rate | 47.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 16 Apr 2024 |
Recent future growth updates
Recent updates
We're Keeping An Eye On IceCure Medical's (NASDAQ:ICCM) Cash Burn Rate
Nov 29
Is IceCure Medical (NASDAQ:ICCM) In A Good Position To Deliver On Growth Plans?
Aug 08IceCure gains 19% on seeking FDA nod for cancer treatment
Oct 19IceCure files application for approval of ProSense in Canada for tumors
Jul 25IceCure Medical: Advancing Cryotherapy For Cancer Treatment
Jan 25Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 34 | -1 | -12 | N/A | 1 |
| 12/31/2025 | 10 | -12 | -12 | N/A | 2 |
| 12/31/2024 | 4 | -13 | -15 | N/A | 3 |
| 12/31/2023 | 3 | -15 | -13 | -13 | N/A |
| 9/30/2023 | 3 | -16 | -15 | -14 | N/A |
| 6/30/2023 | 3 | -16 | -15 | -14 | N/A |
| 3/31/2023 | 3 | -16 | -15 | -14 | N/A |
| 12/31/2022 | 3 | -17 | -15 | -14 | N/A |
| 9/30/2022 | 4 | -16 | -17 | -16 | N/A |
| 6/30/2022 | 4 | -15 | -17 | -16 | N/A |
| 3/31/2022 | 3 | -13 | -14 | -14 | N/A |
| 12/31/2021 | 4 | -10 | -13 | -13 | N/A |
| 9/30/2021 | 4 | -8 | -9 | -8 | N/A |
| 6/30/2021 | 4 | -6 | -7 | -6 | N/A |
| 3/31/2021 | 4 | -4 | -5 | -5 | N/A |
| 12/31/2020 | 4 | -4 | -4 | -4 | N/A |
| 9/30/2020 | 3 | -4 | -2 | -2 | N/A |
| 6/30/2020 | 3 | -4 | -1 | 0 | N/A |
| 3/31/2020 | 2 | -4 | -1 | -1 | N/A |
| 12/31/2019 | 2 | -5 | -2 | -2 | N/A |
| 9/30/2019 | 1 | -5 | N/A | N/A | N/A |
| 6/30/2019 | 1 | -4 | -4 | -4 | N/A |
| 3/31/2019 | 1 | -4 | -4 | -4 | N/A |
| 12/31/2018 | 1 | -4 | -3 | -3 | N/A |
| 9/30/2018 | 1 | -3 | N/A | N/A | N/A |
| 6/30/2018 | 1 | -3 | -3 | -3 | N/A |
| 3/31/2018 | 1 | -3 | -3 | -3 | N/A |
| 12/31/2017 | 1 | -3 | -3 | -3 | N/A |
| 9/30/2017 | 1 | -3 | N/A | -3 | N/A |
| 6/30/2017 | 1 | -3 | N/A | -3 | N/A |
| 3/31/2017 | 1 | -3 | N/A | -3 | N/A |
| 12/31/2016 | 1 | -3 | N/A | -3 | N/A |
| 9/30/2016 | 1 | -3 | N/A | -3 | N/A |
| 6/30/2016 | 1 | -4 | N/A | -4 | N/A |
| 3/31/2016 | 1 | -4 | N/A | -3 | N/A |
| 12/31/2015 | 1 | -4 | N/A | -3 | N/A |
| 9/30/2015 | 1 | -4 | N/A | -3 | N/A |
| 6/30/2015 | 1 | -4 | N/A | -3 | N/A |
| 3/31/2015 | 1 | -4 | N/A | -3 | N/A |
| 12/31/2014 | 1 | -5 | N/A | -3 | N/A |
| 9/30/2014 | 1 | -5 | N/A | -4 | N/A |
| 6/30/2014 | 1 | -5 | N/A | -4 | N/A |
| 3/31/2014 | 0 | -5 | N/A | -3 | N/A |
| 12/31/2013 | 0 | -5 | N/A | -3 | N/A |
| 9/30/2013 | 0 | -5 | N/A | -4 | N/A |
| 6/30/2013 | 0 | -5 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ICCM is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ICCM is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ICCM is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ICCM's revenue (47.8% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: ICCM's revenue (47.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ICCM's Return on Equity is forecast to be high in 3 years time